21st Annual International Congress on Hematologic Malignancies : Focus on Leukemias, Lymphomas and Myeloma

21st Annual International Congress on Hematologic Malignancies : Focus on Leukemias, Lymphomas and Myeloma is organized by Physicians Education Resource, LLC (PER) and would be held during Feb 23 - 25, 2017 at Trump International Beach Resort, Sunny Isles Beach, Florida, United States of America

Target Audience :

This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.

Learning Objectives

At the conclusion of this symposium, you should be better prepared to :

• Describe current and evolving genomic and molecular biomarkers that can be used to stratify risk and inform clinical decision-making in the management of hematologic malignancies
• Assess landmark clinical trial results in the context of how they impact evolving clinical practice paradigms and can be applied to personalize care and optimize outcomes
• Delineate effective strategies to proactively mitigate and manage predictable side effects related to the management of hematologic malignancies so that treatment outcomes can be maximized
• Evaluate recent clinical trial findings concerning novel compounds or strategies to manage hematologic malignancies
• Consider the therapeutic implications of emerging data on evolving treatment paradigms for patients with hematologic tumors